Deutsch English Français

Contact

EP2301961

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2301961

EP2301961 - SCLEROSTIN EPITOPES [Right-click to bookmark this link]
Former [2011/13]	Sclerostin epitopes
	[2016/32]
Status	Patent maintained as amended Status updated on 09.06.2023 Database last updated on 24.04.2024
Former	The patent has been granted Status updated on 20.01.2017
Former	Grant of patent is intended Status updated on 11.01.2017
Former	Examination is in progress Status updated on 25.11.2016
Former	Grant of patent is intended Status updated on 22.11.2016
Most recent event Tooltip	10.11.2023	Correction of patent specification	published on 13.12.2023 [2023/50]
Applicant(s)	For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1799 / US
	[2016/48]
Former [2011/13]	For all designated states UCB Pharma, S.A. Allée de la Recherche 60 1070 Bruxelles / BE
	For all designated states Amgen, Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US
Inventor(s)	01 / Lu, Hsieng Sen 2758 Rainfield Avenue Westlake Village California 91362 / US
	02 / Paszty, Christopher 1027 Westridge Drive Ventura California 93003 / US
	03 / Robinson, Martyn Kim Nursery Cottage Harvey Hill Woodburn Green Buckinghamshire HP10 0JH / GB
	04 / Henry, Alistair James 92 Cowley Road Uxbridge Middlesex UB 8 2LX / GB
	05 / Hoffmann, Kelly Sue 795 Green Valley Drive Newbury Park California 91320 / US
	06 / Latham, John 2409 10th Avenue West Seattle Washington 98119 / US
	07 / Lawson, Alastair 208 Bath Road Slough Berkshire SL1 3WE / GB
	08 / Winkler, David 127 George Street Arlington Massachusetts 02476-7326 / US
	09 / Winters, Aaron George 2501 Pierpont Boulevard Ventura California 93001 / US
	[2017/08]
Former [2011/13]	01 / Lu, Hsieng Sen 2758 Rainfield Avenue Westlake Village California 91362 / US
	02 / Paszty, Christopher 1027 Westridge Drive Ventura California 93003 / US
	03 / Robinson, Martyn Kim Nursery Cottage Harvey Hill Woodburn Green Buckinghamshire HP10 0JH / GB
	04 / Henry, Alistair James 92 Cowley Road Uxbridge Middlesex UB 8 2LX / GB
	05 / Hoffmann, Kelly Sue 795 Green Valley Drive Newbury Park California 91320 / US
	06 / Latham, John 2409 10th Avenue West Seattle Washington 98119 / US
	07 / Lawson, Alastair 208 Bath Road Slough Berkshire SL1 3WE / GB
	08 / Winkler, David 127 George Street Arlington Massachusetts 02476-7326 / US
	09 / Winters, Aaron George 2501 Pierpont Boulevard Ventura California 93001 / US
Representative(s)	J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB
	[2023/28]
Former [2017/08]	Campbell, Patrick John Henry J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
Former [2011/13]	Campbell, Patrick John Henry J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB
Application number, filing date	10014373.4	28.04.2006
	[2011/13]
Priority number, date	US20050677583P	03.05.2005 Original published format: US 677583 P
	US20060776847P	24.02.2006 Original published format: US 776847 P
	US20060782244P	13.03.2006 Original published format: US 782244 P
	US20060792645P	17.04.2006 Original published format: US 792645 P
	US20060410540	25.04.2006 Original published format: US 410540
	[2011/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2301961
	Date:	30.03.2011
	Language:	EN
	[2011/13]
	Type:	B1 Patent specification
	No.:	EP2301961
	Date:	22.02.2017
	Language:	EN
	[2017/08]
	Type:	B2 New European patent specification
	No.:	EP2301961
	Date:	12.07.2023
	Language:	EN
	[2023/28]
	Type:	B9 Corrected patent specification
	No.:	EP2301961
	Date:	13.12.2023
	[2023/50]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	24.02.2011
Classification	IPC:	A61K39/00, C07K16/18, C07K16/22, C12N15/63, C07K14/51	[2016/31]
	CPC:	C07K14/51 (EP,US); C07K16/18 (US); A61P15/12 (EP); A61P19/00 (EP); A61P19/08 (EP); A61P19/10 (EP); (+) A61P43/00 (EP); C07K16/22 (EP,US); C12N15/63 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,US); C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
	Former IPC [2011/13]	C07K14/51, A61K38/10, A61K38/17
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2017/08]
Former [2011/13]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
Extension states	AL	14.09.2011
	BA	14.09.2011
	HR	14.09.2011
	MK	14.09.2011
	YU	14.09.2011
Title	German:	SCLEROSTIN EPITOPE	[2016/31]
	English:	SCLEROSTIN EPITOPES	[2016/32]
	French:	EPITOPES DE LA SCLEROSTIN	[2023/28]
	Former [2011/13]	Sclerostin Epitope
	Former [2011/13]	Sclerostin epitopes
	Former [2011/13]	Epitopes de la sclerostin
Examination procedure	14.09.2011	Examination requested [2011/43]
	07.11.2011	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
	17.01.2012	Amendment by applicant (claims and/or description)
	05.08.2014	Despatch of a communication from the examining division (Time limit: M06)
	16.02.2015	Reply to a communication from the examining division
	15.07.2015	Despatch of a communication from the examining division (Time limit: M06)
	15.01.2016	Reply to a communication from the examining division
	20.07.2016	Communication of intention to grant the patent
	18.11.2016	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	18.11.2016	Fee for grant paid
	18.11.2016	Fee for publishing/printing paid
	11.01.2017	Information about intention to grant a patent
	11.01.2017	Receipt of the translation of the claim(s)
Parent application(s) Tooltip	EP06751835.7 / EP1891100
	EP10006930.1 / EP2251351
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060751835) is 30.10.2008
Opposition(s)	Opponent(s)	01 22.11.2017 28.11.2017 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		[2021/37]
	Former [2018/01]
	Opponent(s)	01 22.11.2017 28.11.2017 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Marshall, Cameron John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	11.12.2017	Invitation to proprietor to file observations on the notice of opposition
	30.04.2018	Reply of patent proprietor to notice(s) of opposition
	16.01.2019	Cancellation of oral proceeding that was planned for 12.06.2019
	01.03.2019	Cancellation of oral proceeding that was planned for 07.11.2019
	12.06.2019	Date of oral proceedings
	07.11.2019	Date of oral proceedings
	13.11.2019	Date of oral proceedings
	06.12.2019	Despatch of interlocutory decision in opposition
	06.12.2019	Despatch of minutes of oral proceedings
	03.02.2023	Legal effect of interlocutory decision in opposition
	22.02.2023	Despatch of communication that the patent will be maintained as amended
	31.05.2023	Fee for printing new specification paid
Appeal following opposition	14.02.2020	Appeal received No. T0398/20
	01.05.2020	Statement of grounds filed
	03.02.2023	Result of appeal procedure: appeal of the opponent withdrawn
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	17.01.2012	Request for further processing filed
	17.01.2012	Full payment received (date of receipt of payment) Request granted
	25.01.2012	Decision despatched
Fees paid	Renewal fee
	03.02.2011	Renewal fee patent year 03
	03.02.2011	Renewal fee patent year 04
	03.02.2011	Renewal fee patent year 05
	12.04.2011	Renewal fee patent year 06
	28.03.2012	Renewal fee patent year 07
	12.04.2013	Renewal fee patent year 08
	25.03.2014	Renewal fee patent year 09
	10.04.2015	Renewal fee patent year 10
	11.04.2016	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XY]WO2005003158 (CELLTECH R & D INC [US], et al) [X] 15-20 * sequences 74, 76, 98 * * page 41, line 5 - line 7 * * page 46, line 22 - line 25 * [Y] 1-20;
		[XY]WO2005014650 (CELLTECH R & D INC [US], et al) [X] 15-20 * sequences 29, 31, 53 * * page 6, line 23 - line 28 * [Y] 1-20;
		[Y] - VITER S S ET AL, "Analysis of antigenic structure of Potato Virus M Ukrainian strains", BIOPOLIMERY I KLETKA, NAUKOVA DUMKA, KIEV, UK, (20000701), vol. 16, no. 4, ISSN 0233-7657, pages 312 - 319, XP009144175 [Y] 1 * page 315, column 1, paragraph 2 *
		[A] - AVSIAN-KRETCHMER ORNA ET AL, "Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists.", MOLECULAR ENDOCRINOLOGY, (200401), vol. 18, no. 1, ISSN 0888-8809, pages 1 - 12, XP002400896 [A] 1-20 * the whole document *
	by applicant	US4179337
		US4301144
		US4331647
		US4411993
		US4464456
		US4496689
		US4543439
		USRE32011E
		US4640835
		US4670417
		US4791192
		US4902614
		WO9202551
		US5145684
		US5223409
		US5399363
		US5466468
		US5543158
		US5552157
		US5565213
		US5567434
		US5627052
		US5641515
		US5698426
		US5738868
		US5795587
		US5877397
		US6133426
		US6395511
		US2004009535
		US6703199
		US2004146888
		US6803453
		US2005106683
		US2005238646
		- RIGGS, WEST J. MED., (1991), vol. 154, pages 63 - 77
		- BRUNKOW ET AL., AM. J. HUM. GENET., (2001), vol. 68, pages 577 - 589
		- BALEMANS ET AL., HUM. MOL. GENET., (2001), vol. 10, pages 537 - 543
		- HOLLINGER; HUDSON, NATURE BIOTECHNOLOGY, (2005), vol. 23, no. 9, pages 1126 - 1136
		- NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., (1960), vol. 89, page 230
		- PORTER, BIOCHEM. J., (1959), vol. 73, page 119
		- EDELMAN ET AL., Methods in Enzymology, ACADEMIC PRESS, (1967), vol. 1, page 422
		- ANDREWS, S.M.; TITUS, J.A. ET AL., Current Protocols in Immunology, JOHN WILEY & SONS, (2003), pages 2.8.1 - 2.8.10,2
		- LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 106
		- "Genetic Manipulation of Monoclonal Antibodies", COURTENAY-LUCK ET AL., Monoclonal Antibodies: Production, Engineering and Clinical Application, CAMBRIDGE UNIVERSITY PRESS, (1995), page 166
		- "Genetic Manipulation and Expression of Antibodies", WARD ET AL., Monoclonal Antibodies: Principles and Applications, WILEY-LISS, INC., (1995), page 137
		- MOULT J., CURR. OP. IN BIOTECH., (1996), vol. 7, no. 4, pages 422 - 427
		- CHOU ET AL., BIOCHEMISTRY, (1974), vol. 13, no. 2, pages 222 - 245
		- CHOU ET AL., BIOCHEMISTRY, (1974), vol. 113, no. 2, pages 211 - 222
		- CHOU ET AL., ADV. ENZYMOL. RELAT AREAS MOL. BIOL., (1978), vol. 47, pages 45 - 148
		- CHOU ET AL., ANN. REV. BIOCHEM., vol. 47, pages 251 - 276
		- CHOU ET AL., BIOPHYS. J., (1979), vol. 26, pages 367 - 384
		- HOLM ET AL., NUCL. ACID. RES., (1999), vol. 27, no. 1, pages 244 - 247
		- BRENNER ET AL., CURR. OP. STRUCT. BIOL., (1997), vol. 7, no. 3, pages 369 - 376
		- JONES, D., CURR. OPIN. STRUCT. BIOL., (1997), vol. 7, no. 3, pages 377 - 87
		- SIPPL ET AL., STRUCTURE, (1996), vol. 4, no. 1, pages 15 - 19
		- BOWIE ET AL., SCIENCE, (1991), vol. 253, pages 164 - 170
		- GRIBSKOV ET AL., METH. ENZYM., (1990), vol. 183, pages 146 - 159
		- GRIBSKOV ET AL., PROC. NAT. ACAD. SCI., (1987), vol. 84, no. 13, pages 4355 - 4358
		- THORNTON ET AL., NATURE, (1991), vol. 354, page 105
		- NYGREN; UHLEN, CURRENT OPINION IN STRUCTURAL BIOLOGY, (1997), vol. 7, pages 463 - 469
		- ZHANG, W. ET AL., MOLECULAR IMMUNOLOGY., (2005), vol. 42, no. 12, pages 1445 - 1451
		- HWANG W. ET AL., METHODS, (2005), vol. 36, no. 1, pages 35 - 42
		- DAU'ACQUA WF ET AL., METHODS, (2005), vol. 36, no. 1, pages 43 - 60
	- CLARK, M., IMMUNOLOGY TODAY, (2000), vol. 21, no. 8, pages 397 - 402
	- PLUCKTHUN ET AL., METHODS ENZYMOL., (1989), vol. 178, pages 497 - 515
	- SANGER ET AL., PNAS, (1977), vol. 74, page 5463
	- KRAMER ET AL., NUCLEIC ACIDS RES., (1984), vol. 12, page 9441
	- KUNKEL, PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 488 - 92
	- KUNKEL ET AL., METHODS IN ENZYMOL., (1987), vol. 154, pages 367 - 82
	- YANG ET AL., J. MOL. BIOL., (1995), vol. 254, pages 392 - 403
	- MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783
	- LOW ET AL., J. MOL. BIOL., (1996), vol. 250, pages 350 - 368
	- PATTEN ET AL., CURR. OPIN. BIOTECLMOL., (1997), vol. 8, pages 724 - 733
	- THOMPSON ET AL., J. MOL. BIOL., (1996), vol. 256, pages 7 - 88
	- CRAMERI ET AL., NATURE, (1998), vol. 391, pages 288 - 291
	- VAUGHAN ET AL., NATURE BIOTECHNOLOGY, (1998), vol. 16, pages 535 - 539
	- KOHLER ET AL., NATURE, (1975), vol. 256, page 495
	- COLIGAN ET AL., Current Protocols in Immunology, JOHN WILEY & SONS, (1991), vol. 1
	- "Production of monoclonal antibodies against proteins expressed in E. coli", PICKSLEY ET AL., DNA Cloning 2: Expression Systems, OXFORD UNIVERSITY PRESS, (1995), page 93
	- "Purification of Immunoglobulin G (IgG)", BAINES ET AL., Methods in Molecular Biology, HUMANA PRESS, INC., (1992), vol. 10, pages 79 - 104
	- GREEN ET AL., NATURE GENET., (1994), vol. 7, page 13
	- LONBERG, NATURE, (1994), vol. 368, page 856
	- TAYLOR, INT. IMMUN., (1994), vol. 6, page 579
	- BRUGGEMANN, CURR. OPIN. BIOTECHNOL., (1997), vol. 8, pages 455 - 58
	- JAKOBOVITS ET AL., ANN. N. Y. ACAD SCI., (1995), vol. 764, pages 525 - 35
	- BRUGGEMANN ET AL., CURR. OPIN. BIOTECHNOL., (1997), vol. 8, pages 455 - 58
	- GLASKY ET AL., HYBRIDOMA, (1989), vol. 8, pages 377 - 89
	- BOERNER ET AL., J LMMUNOL., (1991), vol. 147, pages 86 - 95
	- BABCOOK ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 7843 - 48
	- WINTER ET AL., ANNU. REV: IMMUNOL., (1994), vol. 12, pages 433 - 55
	- BURTON ET AL., ADV. IMMUNOL., (1994), vol. 57, pages 191 - 280
	- HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 81
	- SASTRY ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 5728 - 32
	- ALTING-MEES ET AL., STRATEGIES IN MOLECULAR BIOLOGY, (1990), vol. 3, pages 1 - 9
	- KANG ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 4363 - 66
	- HOOGENBOOM ET AL., J. MOLEC. BIOL., (1992), vol. 227, pages 381 - 388
	- SCHLEBUSCH ET AL., HYBRIDOMA, (1997), vol. 16, pages 47 - 52
	- BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
	- HARRIS, RJ., JOURNAL OF CHROMATOGRAPHY, (1995), vol. 705, pages 129 - 134
	- ANGAL SET, MOL IMMUNOL, (1993), vol. 30, no. 1, pages 105 - 108
	- SCATCHARD, ANN. N.Y. ACAD. SCI., (1949), vol. 51, pages 660 - 672
	- WOLFF ET AL., CANCER RES., (1993), vol. 53, pages 2560 - 65
	- SUDO H; KODAMA H-A; AMAGAI Y; YAMAMOTO S; KASAI S, "vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria", J. CELL BIOL., (1983), vol. 96, doi:doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687 DOI: http://dx.doi.org/10.1083/jcb.96.1.191
	- SMITH E; REDMAN R; LOGG C; COETZEE G; KASAHARA N; FRENKEL B, "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", J. BIOL. CHEM., (2000), vol. 275, pages 19992 - 20001
	- Remington's Pharmaceutical Sciences, pages 1035 - 1038,157
	- LASIC, TRENDS BIOTECHNOL., (1998), vol. 16, no. 7, pages 307 - 21
	- TAKAKURA, NIPPON RINSHO, (1998), vol. 56, no. 3, pages 691 - 95
	- CHANDRAN ET AL., INDIAN J. EXP. BIOL., (1997), vol. 35, no. 8, pages 801 - 09
	- MARGALIT, CRIT. REV. THER. DRUG CARRIER SYST., (1995), vol. 12, no. 2-3, pages 233 - 61
	- QUINTANAR-GUERRERO ET AL., DRUG DEV. IND PHARM., (1998), vol. 24, no. 12, pages 1113 - 28
	- COUVREUR ET AL., CRIT. REV. THER. DRUG CARRIER SYST., (1988), vol. 5, no. 1, pages 1 - 20
	- ZUR MUHLEN ET AL., EUR. J. PHARM. BIOPHARM., (1998), vol. 45, no. 2, pages 149 - 55
	- ZAMBAUX ET AL., J CONTROLLED RELEASE, (1998), vol. 50, no. 1-3, pages 31 - 40
	- COMIER, CURR. OPIN. IN RHEU., (1995), vol. 7, page 243
	- GUINNESS-HEY, METAB. BONE DIS. RELAT. RES., (1984), vol. 5, pages 177 - 181
	- KALU, D.N., "The ovariectomized rat model ofpostmenopausal bone loss", BONE AND MINERAL, (1991), vol. 15, pages 175 - 192
	- FROST, H.M.; JEE, W.S.S., "Qn the rat'model of human osteopenias and osteoporosis", BONE AND MINERAL, (1992), vol. 18, doi:doi:10.1016/0169-6009(92)90809-R, pages 227 - 236, XP023072088 DOI: http://dx.doi.org/10.1016/0169-6009(92)90809-R
	- JEE, W.S.S.; YAO, W., "Overview: animal models of osteopenia and osteoporosis", J MUSCULOSKEL. NEURON. INTERACT., (2001), vol. 1, pages 193 - 207
	- SUDO H ET AL., "vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria", J. CELL BIOL., vol. 96, doi:doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687 DOI: http://dx.doi.org/10.1083/jcb.96.1.191
	- SMITH E; REDMAN R; LOGG C; COETZEE Q; KASAHARA N; FRENKEL B, "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", J BIOL CHEM, (2000), vol. 275, pages 19992 - 20001
	- SUDO H; KODAMA H-A; AMAGAI Y; YAMAMOTO S; KASAI S, "vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria", J CELL BIOL, (1983), vol. 96, doi:doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687 DOI: http://dx.doi.org/10.1083/jcb.96.1.191
	- BYRNE, F. R. ET AL., GUT, (2005), vol. 54, pages 78 - 86
	US20030478977
	US20040868497
	Opposition	WO0032773
		WO2005003158
		WO2005014650
		- VITER et al., "Analysis of antigenic structure of Potato Virus M Ukrainian strains", Biopolymers & Cell, (20000000), vol. 16, no. 4, pages 312 - 319, XP009144175
		- AVSIAN-KRETCHMER et al., "Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists", Mol. Endocrinol., (20040000), vol. 18, no. 1, pages 1 - 12, XP002400896
		- HUGO et al., "Functional aspects of co-variant surf ace charges in an antibody fragment", Prot. Sci., (20020000), vol. 11, pages 2697 - 2705, XP055261739
		- Warmington K. et al., "Sclerostin Antagonism in Adult Rodents, via Monoclonal Antibody Mediated Blockade, Increases Bone Mineral Density and Implicates Sclerostin as a Key Regulator of Bone Mass During Adulthood", Oasis, Online Abstract Submission and Invitation System, (20040000), XP009072609 DOI: http://dx.doi.org/10.1359/JBMR.0301211
		- Declaration of Chris Paszty of 14 June 2012
		- Reverberi and Reverberi, 2007, Blood Transfus., 5, 227-240
		- Lee and Kerns (1999) LS/MS Applications in Drug Development, Mass Spectrometry Reviews 18, 187-279
		- Robb et al. (2000), Anal. Chem., 72. 3653-3659
		- Arpino et al. (1989) Mass Spectrometry Reviews, 8, 35-55
		- Ardrey (2003), Liquid Chromatography - Mass Spectrometry: An Introduction. John Wiley & Sons, Ltd
		- Niessen (2006). Liquid Chromatography - Mass Spectrometry, Third Edition. Boca Raton: CRC Taylor & Francis
		- Declaration of Prof. Schwartz
		- New continuous chemistry systems offers the widest range of reactions
		- Syrris Releae. New continuous chemistry system offers the widest range of reactions
		- A. Raines "The Calvin Cycle Revisited" - 18.04.2022

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p